// App-Quantinova.ai

363 : Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches

Researchers

Presenter

  • Ricardo Sanchez

Principal Investigators

  • Juan Manuel de la Rosa

  • Yanira Heredia

  • Jaime Carrillo

  • Laura Rufian

  • Esther Onecha

  • Gonzalo Carreo Gomez-Tarragona

  • Chongwu Wang

  • Mara Linares

  • Jose Sanchez-Pina

  • Inmaculada Rapado

  • Josep-Maria Ribera

  • Rosa Ayala

  • Joaquin Martinez-Lpez

  • Santiago Barrio

Medical Centers

  • Hematology Department, Hospital Universitario La Princesa, Madrid, Spain

  • Altum sequencing Co., Madrid, Spain

  • Hematology Department, Hospital Universitario La Princesa, Madrid, Spain

  • Hosea Precision Medical Technology Co., Ltd., Weihai, Shangdong, China

  • Hospital Germans Trias i Pujol, Barcelona, Spain

  • hematology,Hospital Universitario 12 de Octubre,Madrid,Spain;Hematological Malignancies Clinical Research Unit,Spanish National Cancer Research Center,Madrid,Spain

Locations

  • Spain

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Vascular endothelial growth factor B

Drug/Treatment

  • Ponatinib

  • dasatinib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved